Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Viborg
Clinical trial register · Denmark

Clinical Trials in Viborg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2469 matching records held by the registry are in this view. Synced 16 Oct 2026, 03:17 UTC
2469
Studies in scope
all four open statuses
1395
Recruiting now
open to new participants
438
Lead sponsors
across recruiting studies
Top sites
Copenhagen 974 Aarhus 586 Odense 441 Aalborg 384 Herlev 314
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Aarhus9 Central Jutland Regional Hospital3 Aarhus University Hospital3 AstraZeneca2 Novartis Pharmaceuticals2
Site location
Copenhagen974 Aarhus586 Odense441 Aalborg384 Herlev314
All 128 locations
Target enrolment
to

Trials with a site in Viborg

42 of 2469 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Not yet open
IRONCARE: Iron Treatment in Older Patients With Hip Fractures
NCT07659184Hip Fracture, Anemia, Iron, Placebo - Control
DrugsIron·Ferric Derisomaltose
University of Aarhus
Phase 4
528
Aarhus N, Herning, Horsens, Randers, Viborg
2026-10-01
Recruiting
Arrowhead Pharmaceuticals
Phase 3
10
Viborg
2026-10
Not yet open
Oral Immunotherapy for Children With Cow's Milk Allergy
NCT07768696Milk Allergy, Cow's, Food Allergy in Children, Food Allergies
Laura Ozer Kettner
Not applicable
56
Aarhus, Gødstrup, Kolding, Randers, Viborg
2026-09
Recruiting
AstraZeneca
Phase 3
600
Aarhus, Copenhagen, Gandrup, Herlev, Herning, Svendborg, Vejle, Viborg
2026-08-12
Not yet open
Aarhus University Hospital
Not applicable
15
Aarhus N, Horsens, Viborg
2026-07
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
Viborg, Gandrup, Esbjerg, Svendborg
2026-06-30
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Aarhus N, Copenhagen, Esbjerg, Gistrup, Herlev, Roskilde, Viborg
2026-05-11
Recruiting
Amgen
Phase 3
406
Herning, Viborg
2026-03-23
Active, closed
Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes
NCT07375797Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test, Continuous Glucose Monitoring
Central Jutland Regional Hospital
Not applicable
16
Viborg
2026-02-05
Recruiting
University of Aarhus
Not applicable
617
Aarhus, Herning, Horsens, Randers, Silkeborg, Viborg
2026-01-01
Recruiting
The MICRON Study - A Steno 1 Substudy
NCT07270172Type 1 Diabetes Mellitus
University of Aarhus
Observational
40
Aarhus N, Gødstrup, Horsens, Silkeborg, Viborg
2025-10-27
Recruiting
The AIDPRO-CRC Trial
NCT06645015Colo-rectal Cancer
Zealand University Hospital
Not applicable
1,200
Aalborg, Copenhagen NV, Herning, Hillerød, Hvidovre, Randers, Svendborg, Viborg
2025-10-24
Recruiting
Acesion Pharma
Phase 2
200
Hellerup, Viborg
2025-10-22
By invitation
Central Jutland Regional Hospital
Not applicable
50
Viborg
2025-10-21
Recruiting
Tampere University Hospital
Not applicable
532
Viborg
2025-08-01
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Aarhus N, Copenhagen, Esbjerg, Herlev, Herning, Hvidovre, Viborg
2025-06-10
Recruiting
Louise Møldrup Nielsen
Not applicable
50
Viborg
2025-05-02
Recruiting
University of Aarhus
Phase 4
5,076
Herning, Horsens, Viborg, Aalborg, Aabenraa, Esbjerg, Kolding, Odense
2025-05-01
Recruiting
Aarhus University Hospital
Phase 2
250
Aalborg, Aarhus N, Copenhagen, Herning, Hvidovre, Odense, Viborg
2025-03-20
Recruiting
Pfizer
Phase 3
723
Glostrup Municipality, Viborg
2025-03-11
Recruiting
Colorectal Omics and OfCS Proteoglycans
NCT06287671Colorectal Cancer, Diverticulitis, Colonic, Inflammatory Bowel Diseases, Stoma Colostomy
Claus Anders Bertelsen, PhD, MD
Observational
1,000
Hillerød, Viborg
2024-10-08
Active, closed
The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis
NCT07061899Proctitis, Ulcerative, Sexually Transmitted Disease (STD), Ulcerative Proctosigmoiditis
University of Aarhus
Observational
214
Aarhus N, Herning, Randers, Silkeborg, Viborg
2024-10-01
Recruiting
Carsten Dirksen
Not applicable
500
Aarhus, Esbjerg, Hvidovre, Viborg
2024-05-08
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Esbjerg, Hvidovre, Roskilde, Viborg
2024-03-07
Recruiting
The Pro-Chol Study
NCT07245108Gallstones, Gallstone Attack, Uncomplicated Cholelithiasis, Cholecystolithiasis
Nordsjaellands Hospital
Observational
800
Copenhagen, Aalborg, Herlev, Hillerød, Hjørring, Hvidovre, Viborg
2024-01-22
Active, closed
UNEEG Medical A/S
Not applicable
19
Aalborg, Odense, Viborg
2023-12-04
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Viborg, Aarhus, Esbjerg, Copenhagen, Hjørring, Odense C
2023-11-30
Active, closed
Ad scientiam
Not applicable
336
Esbjerg, Glostrup Municipality, Viborg
2023-09-22
Recruiting
Claus Lindbjerg Andersen
Observational
590
Copenhagen, Herlev, Aarhus, Herning, Horsens, Randers, Viborg, Aalborg
2023-08-01
Recruiting
DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies
NCT06076811Colorectal Neoplasms, Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Stage I
University of Aarhus
Observational
1,600
Copenhagen, Herlev, Aarhus, Herning, Horsens, Randers, Viborg, Aalborg
2023-08-01
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Aalborg, Aarhus, Esbjerg, Viborg
2022-12-13
Active, closed
IMPROVE-pT1: Accurate Allocation of Completion Resection in Early Colorectal Cancer
NCT06040632Colorectal Cancer, Colorectal Polyp, Colorectal Cancer Stage I
University of Aarhus
Observational
67
Copenhagen, Herlev, Aarhus, Herning, Horsens, Randers, Viborg, Aalborg
2022-09-01
Recruiting
Morten Steen Kvistholm Jensen
Phase 4
100
Aarhus N, Odense, Roskilde, Viborg
2022-08-10
Recruiting
Hospital at Home for Elderly Acute Ill Patients
NCT05360914Cystitis, Erysipelas, Pneumonia
Defactum, Central Denmark Region
Not applicable
849
Silkeborg, Skive, Viborg
2022-06-01
Active, closed
The Diverticulitis Study
NCT06023004Colonic Diverticulitis, Colorectal Cancer, Acute Diverticulitis
University of Aarhus
Observational
250
Herlev, Horsens, Randers, Viborg, Odense
2022-05-01
Recruiting
AQT90 FLEX D-dimer Clinical Sensitivity and Specificity
NCT06749223VTE (Venous Thromboembolism)
Radiometer Medical ApS
Observational
600
Viborg
2022-04-04
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
Aalborg, Copenhagen, Esbjerg, Herning, Viborg
2022-02-07
By invitation
Aarhus University Hospital
Observational
2,000
Aarhus N, Gødstrup, Horsens, Randers, Viborg
2022-01-01
Recruiting
University of Aarhus
Not applicable
102
Aarhus N, Esbjerg, Farsø, Silkeborg, Viborg
2021-05-28
Recruiting
Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy
NCT03730922Breast Neoplasm Female, Complication of Radiation Therapy, Breast Implant; Complications
Danish Breast Cancer Cooperative Group
Not applicable
590
Aabenraa, Aalborg, Aarhus, Copenhagen, Esbjerg, Roskilde, Vejle, Viborg
2020-01-01
Active, closed
Anna Martling
Phase 3
626
Aarhus, Randers, Viborg
2016-04-07
By invitation
Central Jutland Regional Hospital
Observational
4,500
Viborg
2014-08-01
Rows per page Showing 1–42 of 42
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 October 2026. https://priyalifescience.com/clinical-trials-denmark/city/viborg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,469 studies in total at the last sync on 16 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 42 of those studies with a site in Viborg.

How many clinical trials are recruiting in Viborg?

25 of the 42 studies on this page are recruiting new participants as of the 16 Oct 2026, 03:17 UTC sync. A further 3 have not yet opened recruitment, 11 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Viborg), 42 studies
PhaseStudiesRecruitingShare
Not applicable15935.7%
Observational11626.2%
Phase 39421.4%
Phase 2449.5%
Phase 4327.1%

Most active sponsors

Lead sponsors with the most studies (Viborg)
Lead sponsorStudiesRecruiting
University of Aarhus95
Aarhus University Hospital31
Central Jutland Regional Hospital30
AstraZeneca21
Novartis Pharmaceuticals21
Acesion Pharma11
Ad scientiam10
Amgen11
Anna Martling10
Arrowhead Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.